Crossref
228 Impact of Biologic Class on Ocular Outcomes in Psoriasis: Insights from a Multi-Institutional Database Study
Journal of Investigative Dermatology · 2025-11 · 145 (11) · e67
DOI: 10.1016/j.jid.2025.09.232 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2025-11. Verfasst von Robert Adler und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Adler, R., Kozlov, M., Gandhi, I., & Feig, J. (2025). 228 Impact of Biologic Class on Ocular Outcomes in Psoriasis: Insights from a Multi-Institutional Database Study. Journal of Investigative Dermatology, 145(11), e67. https://doi.org/10.1016/j.jid.2025.09.232
Vancouver
Adler R, Kozlov M, Gandhi I, Feig J. 228 Impact of Biologic Class on Ocular Outcomes in Psoriasis: Insights from a Multi-Institutional Database Study. Journal of Investigative Dermatology. 2025;145(11):e67. doi:10.1016/j.jid.2025.09.232
BibTeX
@article{Adler2025,
author = {Adler, Robert and Kozlov, Michael and Gandhi, Isha and Feig, Jessica},
title = {228 Impact of Biologic Class on Ocular Outcomes in Psoriasis: Insights from a Multi-Institutional Database Study},
journal = {Journal of Investigative Dermatology},
year = {2025},
volume = {145},
number = {11},
pages = {e67},
doi = {10.1016/j.jid.2025.09.232}
}
EUVIMED